Clinical characteristics and survival of esophageal cancer patients: annual report of the surgical treatment in Shanghai Chest Hospital, 2017.

Chang Yuan Xiaolu Wu Yuxin YangZhichao LiuYifeng SunXufeng GuoBin LiRong HuaYang YangTeng MaoHong ZhangYuchen SuChunguang LiShan-Shan Geng Zhi-Gang Li

Published in: Journal of thoracic disease (2024)

The 5-year OS of patients with esophageal cancer can reach 52.5% after surgical treatment in 2017 at SCH. The exact beneficiaries of neoadjuvant therapy are still unclear in the 2017 cohort.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
prognostic factors
lymph node
peritoneal dialysis
emergency department
squamous cell carcinoma
mesenchymal stem cells
replacement therapy